Global Zika Virus Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Zika Virus Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

According to APO Research, The global Zika Virus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Zika Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Zika Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Zika Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Zika Virus is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Zika Virus include Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Zika Virus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Zika Virus, also provides the sales of main regions and countries. Of the upcoming market potential for Zika Virus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Virus sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Zika Virus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Zika Virus sales, projected growth trends, production technology, application and end-user industry.

Zika Virus segment by Company

Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Zika Virus segment by Type

Molecular Test
Serologic Test
Zika Virus segment by Application

Diagnostic Centers
Hospitals
Pathology Labs
Zika Virus segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Zika Virus status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Zika Virus market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Zika Virus significant trends, drivers, influence factors in global and regions.
6. To analyze Zika Virus competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zika Virus market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zika Virus industry.
Chapter 3: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Zika Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Zika Virus in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Zika Virus Sales Value (2019-2030)
1.2.2 Global Zika Virus Sales Volume (2019-2030)
1.2.3 Global Zika Virus Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Zika Virus Market Dynamics
2.1 Zika Virus Industry Trends
2.2 Zika Virus Industry Drivers
2.3 Zika Virus Industry Opportunities and Challenges
2.4 Zika Virus Industry Restraints
3 Zika Virus Market by Company
3.1 Global Zika Virus Company Revenue Ranking in 2023
3.2 Global Zika Virus Revenue by Company (2019-2024)
3.3 Global Zika Virus Sales Volume by Company (2019-2024)
3.4 Global Zika Virus Average Price by Company (2019-2024)
3.5 Global Zika Virus Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Zika Virus Company Manufacturing Base & Headquarters
3.7 Global Zika Virus Company, Product Type & Application
3.8 Global Zika Virus Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Zika Virus Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Zika Virus Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Zika Virus Market by Type
4.1 Zika Virus Type Introduction
4.1.1 Molecular Test
4.1.2 Serologic Test
4.2 Global Zika Virus Sales Volume by Type
4.2.1 Global Zika Virus Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Zika Virus Sales Volume by Type (2019-2030)
4.2.3 Global Zika Virus Sales Volume Share by Type (2019-2030)
4.3 Global Zika Virus Sales Value by Type
4.3.1 Global Zika Virus Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Zika Virus Sales Value by Type (2019-2030)
4.3.3 Global Zika Virus Sales Value Share by Type (2019-2030)
5 Zika Virus Market by Application
5.1 Zika Virus Application Introduction
5.1.1 Diagnostic Centers
5.1.2 Hospitals
5.1.3 Pathology Labs
5.2 Global Zika Virus Sales Volume by Application
5.2.1 Global Zika Virus Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Zika Virus Sales Volume by Application (2019-2030)
5.2.3 Global Zika Virus Sales Volume Share by Application (2019-2030)
5.3 Global Zika Virus Sales Value by Application
5.3.1 Global Zika Virus Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Zika Virus Sales Value by Application (2019-2030)
5.3.3 Global Zika Virus Sales Value Share by Application (2019-2030)
6 Zika Virus Market by Region
6.1 Global Zika Virus Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Zika Virus Sales by Region (2019-2030)
6.2.1 Global Zika Virus Sales by Region: 2019-2024
6.2.2 Global Zika Virus Sales by Region (2025-2030)
6.3 Global Zika Virus Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Zika Virus Sales Value by Region (2019-2030)
6.4.1 Global Zika Virus Sales Value by Region: 2019-2024
6.4.2 Global Zika Virus Sales Value by Region (2025-2030)
6.5 Global Zika Virus Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Zika Virus Sales Value (2019-2030)
6.6.2 North America Zika Virus Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Zika Virus Sales Value (2019-2030)
6.7.2 Europe Zika Virus Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Zika Virus Sales Value (2019-2030)
6.8.2 Asia-Pacific Zika Virus Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Zika Virus Sales Value (2019-2030)
6.9.2 Latin America Zika Virus Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Zika Virus Sales Value (2019-2030)
6.10.2 Middle East & Africa Zika Virus Sales Value Share by Country, 2023 VS 2030
7 Zika Virus Market by Country
7.1 Global Zika Virus Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Zika Virus Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Zika Virus Sales by Country (2019-2030)
7.3.1 Global Zika Virus Sales by Country (2019-2024)
7.3.2 Global Zika Virus Sales by Country (2025-2030)
7.4 Global Zika Virus Sales Value by Country (2019-2030)
7.4.1 Global Zika Virus Sales Value by Country (2019-2024)
7.4.2 Global Zika Virus Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.5.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.6.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.7.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.8.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.9.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.10.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.11.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.12.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.13.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.14.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.15.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.16.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.17.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.18.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.19.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.20.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.21.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.22.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Zika Virus Sales Value Growth Rate (2019-2030)
7.23.2 Global Zika Virus Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Zika Virus Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Bharat Biotech
8.1.1 Bharat Biotech Comapny Information
8.1.2 Bharat Biotech Business Overview
8.1.3 Bharat Biotech Zika Virus Sales, Value and Gross Margin (2019-2024)
8.1.4 Bharat Biotech Zika Virus Product Portfolio
8.1.5 Bharat Biotech Recent Developments
8.2 Inovio Pharmaceuticals and GeneOne Life Sciences
8.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Comapny Information
8.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview
8.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Value and Gross Margin (2019-2024)
8.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio
8.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments
8.3 Intrexon
8.3.1 Intrexon Comapny Information
8.3.2 Intrexon Business Overview
8.3.3 Intrexon Zika Virus Sales, Value and Gross Margin (2019-2024)
8.3.4 Intrexon Zika Virus Product Portfolio
8.3.5 Intrexon Recent Developments
8.4 Cerus
8.4.1 Cerus Comapny Information
8.4.2 Cerus Business Overview
8.4.3 Cerus Zika Virus Sales, Value and Gross Margin (2019-2024)
8.4.4 Cerus Zika Virus Product Portfolio
8.4.5 Cerus Recent Developments
8.5 Sanofi
8.5.1 Sanofi Comapny Information
8.5.2 Sanofi Business Overview
8.5.3 Sanofi Zika Virus Sales, Value and Gross Margin (2019-2024)
8.5.4 Sanofi Zika Virus Product Portfolio
8.5.5 Sanofi Recent Developments
8.6 NewLink Genetics
8.6.1 NewLink Genetics Comapny Information
8.6.2 NewLink Genetics Business Overview
8.6.3 NewLink Genetics Zika Virus Sales, Value and Gross Margin (2019-2024)
8.6.4 NewLink Genetics Zika Virus Product Portfolio
8.6.5 NewLink Genetics Recent Developments
8.7 Immunovaccine
8.7.1 Immunovaccine Comapny Information
8.7.2 Immunovaccine Business Overview
8.7.3 Immunovaccine Zika Virus Sales, Value and Gross Margin (2019-2024)
8.7.4 Immunovaccine Zika Virus Product Portfolio
8.7.5 Immunovaccine Recent Developments
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Comapny Information
8.8.2 GlaxoSmithKline Business Overview
8.8.3 GlaxoSmithKline Zika Virus Sales, Value and Gross Margin (2019-2024)
8.8.4 GlaxoSmithKline Zika Virus Product Portfolio
8.8.5 GlaxoSmithKline Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Zika Virus Value Chain Analysis
9.1.1 Zika Virus Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Zika Virus Sales Mode & Process
9.2 Zika Virus Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Zika Virus Distributors
9.2.3 Zika Virus Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings